Display options
Share it on

Cases J. 2009 Jan 27;2(1):89. doi: 10.1186/1757-1626-2-89.

Hepatitis following famotidine: a case report.

Cases journal

Nishant Gupta, Chirag Patel, Mukta Panda

Affiliations

  1. Department of Internal Medicine, University of Tennessee, College of Medicine, Chattanooga, TN 37403, USA. [email protected].

PMID: 19173722 PMCID: PMC2640350 DOI: 10.1186/1757-1626-2-89

Abstract

H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third day of hospitalization with a dramatic rise in his liver enzymes from normal values at the time of admission. The acute rise in liver enzymes made us consider an adverse drug reaction and famotidine was discontinued. Subsequently his liver enzymes came back to normal in seven days. Thus, physicians should consider famotidine induced hepatitis as a possible etiology of acute liver dysfunction.

References

  1. Ann Pharmacother. 1994 Jan;28(1):37-9 - PubMed
  2. Am J Gastroenterol. 2000 Dec;95(12):3665-6 - PubMed
  3. Hepatogastroenterology. 1990 Jul;37 Suppl 1:6-10 - PubMed
  4. Am J Gastroenterol. 1991 Jan;86(1):41-5 - PubMed
  5. J Pharmacol Exp Ther. 2006 May;317(2):635-43 - PubMed
  6. Semin Liver Dis. 2002;22(2):169-83 - PubMed
  7. Ann Intern Med. 2002 Dec 17;137(12):947-54 - PubMed
  8. J Hepatol. 1997 Sep;27(3):583-6 - PubMed
  9. Br J Clin Pharmacol. 1997 Feb;43(2):183-8 - PubMed
  10. J Hepatol. 1999 Oct;31(4):641-6 - PubMed
  11. Arch Intern Med. 1990 Apr;150(4):745-51 - PubMed
  12. Hepatology. 2001 Apr;33(4):1009-13 - PubMed
  13. Eur J Clin Pharmacol. 1992;43(5):559-62 - PubMed
  14. Aliment Pharmacol Ther. 1990 Feb;4(1):83-96 - PubMed

Publication Types